SEMABIZ, Inc. | ChosaReport.com

日本と海外の市場調査レポート＆サービスを取り扱っております。

IPS細胞由来オルガノイド市場調査レポート

IPS Cell Derived Organoids Market Research Report

IPS細胞由来オルガノイド市場調査レポート : タイプ（脳オルガノイド、心臓オルガノイド、肺オルガノイド、肝臓オルガノイド、腎臓オルガノイドなど）、用途（創薬および開発、疾患モデリング、および再生医療）、エンドユーザー (製薬企業およびバイオテクノロジー企業、学術研究機関、受託研究機関)、および地域 (北米、ヨーロッパ、アジア太平洋、およびRoW) - 2032年までの予測
IPS Cell Derived Organoids Market Research Report Information by Type (Brain Organoids, Heart Organoids, Lung Organoids, Liver Organoids, Kidney Organoids, and Others), by Application (Drug Discovery and Development, Disease Modelling, and Regenerative Medicine), by End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Contract Research Organization), and by Region (North America, Europe, Asia-Pacific, and Rest of the World - Forecast till 2032

商品番号 : SMB-69928

出版社Market Research Future
出版年月2024年11月
ページ数101
価格タイプシングルユーザライセンス
価格USD 4,950
種別英文調査報告書

Overview of the Market

IPS Cell Derived Organoids Market size was valued at USD 0.44 billion in 2023. The IPS Cell Derived Organoids Market industry is projected to grow from USD 0.51 billion in 2024 to USD 1.89 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 17.8% during the forecast period (2024 – 2032).

IPS細胞由来オルガノイド市場規模は、2023年に4億4,000万米ドルと評価されました。IPS細胞由来オルガノイド市場業界は、2024年の5億1,000万米ドルから2032年までに18億9,000万米ドルに成長すると予測されており、予測期間 (2024 ～ 2032 年) 中の年平均成長率（CAGR）は17.8倍です。

IPS cell-derived organoids market represent a revolutionary advancement in biomedical research and drug development. These miniature, three-dimensional tissue models, generated from induced pluripotent stem cells (iPSCs), offer unprecedented opportunities for studying human physiology, disease mechanisms, and drug efficacy. Organoids are used in various applications, including disease modelling, drug discovery, personalized medicine, and regenerative therapies. The iPS cell-derived organoids market is poised for substantial growth, driven by technological advancements, increasing demand for personalized medicine, and expanding applications in drug discovery and regenerative medicine. However, overcoming technical, regulatory, and ethical challenges will be crucial for realizing the full potential of this transformative technology.

Perspectives on Market Segments

The IPS Cell Derived Organoids Market segmentation, based on type, includes Brain Organoids, Heart Organoids, Lung Organoids, Liver Organoids, Kidney Organoids, and Others.

The IPS Cell Derived Organoids Market segmentation, based on application, includes drug discovery and development, disease modelling, and regenerative medicine.

Market Regional Insights

The IPS Cell Derived Organoids market in America boasts a robust research infrastructure, substantial investments in life sciences, and a thriving biotechnology industry. North America is home to several top-tier universities and research centers that are at the forefront of stem cell research. This region has seen substantial investments from both public and private sectors aimed at advancing the development and application of iPS cell-derived organoids. The well-established healthcare systems in North America facilitate the adoption of advanced medical technologies. The presence of sophisticated laboratory facilities and skilled professionals further supports market growth. The region’s inclination towards technological adoption has fostered the development and application of organoid-based platforms. Supportive regulatory frameworks encourage investments in organoid research and development.

Europe IPS Cell Derived Organoids market accounted for the second-largest market share due to region’s emphasis on healthcare, coupled with a strong scientific community, drives the market. Furthermore, the Germany IPS Cell Derived Organoids provider attributed to hold the largest market share, and the France IPS Cell Derived Organoids providers is projected be the fastest growing market in the Europe region.

The Asia-Pacific IPS Cell Derived Organoids market is expected to be the fastest growing from 2023 to 2032 due to increasing investments in biomedical research, growing healthcare expenditure, and a rising prevalence of chronic diseases can support IPS Cell Derived Organoids development.

Key Players

Key Companies in the IPS Cell Derived Organoids market includes ACROBiosystems (US), Miltenyi Biotec (Germany), ThermoFisher Scientific (US), STEMCELL Technologies (Canada), Bio-Techne (US), Merck KGaA (Germany), Molecular Devices, LLC (US), Corning Incorporated (US), Promega Corporation (US), and Creative Bioarray (US).

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

2.1 DEFINITION

2.2 SCOPE OF THE STUDY

2.3 RESEARCH OBJECTIVE

2.4 MARKET STRUCTURE

3 RESEARCH METHODOLOGY

3.1 OVERVIEW

3.2 DATA FLOW

3.2.1 DATA MINING PROCESS

3.3 PURCHASED DATABASE:

3.4 SECONDARY SOURCES:

3.4.1 SECONDARY RESEARCH DATA FLOW:

3.5 PRIMARY RESEARCH:

3.5.1 PRIMARY RESEARCH DATA FLOW:

3.5.2 PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED

3.5.3 PRIMARY RESEARCH: REGIONAL COVERAGE

3.6 APPROACHES FOR MARKET SIZE ESTIMATION:

3.6.1 REVENUE ANALYSIS APPROACH

3.7 DATA FORECASTING

3.7.1 DATA FORECASTING TECHNIQUE

3.8 DATA MODELING

3.8.1 MICROECONOMIC FACTOR ANALYSIS:

3.8.2 DATA MODELING:

4 MARKET DYNAMICS

4.1 INTRODUCTION

4.2 DRIVERS

4.2.1 GROWING ADOPTION OF PERSONALIZED DRUGS

4.2.2 RISING PREVALENCE OF CHRONIC DISEASES

4.2.3 ADVANCEMENTS IN STEM CELL RESEARCH

4.2.4 DRIVER IMPACT ANALYSIS

4.3 RESTRAINTS

4.3.1 HIGH COST OF ORGANOID DEVELOPMENT AND MAINTENANCE

4.3.2 REGULATORY HURDLES AND STANDARDIZATION

4.3.3 RESTRAINT IMPACT ANALYSIS

4.4 OPPORTUNITY

4.4.1 DEVELOPMENT OF MORE COMPLEX AND FUNCTIONAL ORGANOIDS

4.4.2 EXPANSION OF APPLICATIONS IN DRUG DISCOVERY AND TOXICOLOGY

4.5 IMPACT ANALYSIS OF COVID – 19

4.5.1 IMPACT ON OVERALL HEALTH INDUSTRY

4.5.2 IMPACT ON GLOBAL IPS CELL-DERIVED ORGANOIDS MARKET

4.5.3 IMPACT ON SUPPLY CHAIN OF IPS CELL-DERIVED ORGANOIDS

4.5.4 IMPACT ON MARKET DEMAND OF IPS CELL-DERIVED ORGANOIDS

4.5.5 IMPACT ON PRICING OF IPS CELL-DERIVED ORGANOIDS

5 MARKET FACTOR ANALYSIS

5.1 PORTER’S FIVE FORCES MODEL

5.1.1 THREAT OF NEW ENTRANTS

5.1.2 BARGAINING POWER OF SUPPLIERS

5.1.3 BARGAINING POWER OF BUYERS

5.1.4 THREAT OF SUBSTITUTES

5.1.5 INTENSITY OF RIVALRY

5.2 SUPPLY CHAIN ANALYSIS

5.2.1 RAW MATERIAL

5.2.2 PRODUCTION PROCESS

5.2.3 DISTRIBUTION

5.2.4 END USER

6 GLOBAL IPS CELL-DERIVED ORGANOIDS MARKET, BY TYPE

6.1 OVERVIEW

6.2 BRAIN

6.3 HEART

6.4 LUNG

6.5 LIVER

6.6 KIDNEY

6.7 OTHERS

7 GLOBAL IPS CELL-DERIVED ORGANOIDS MARKET, BY APPLICATION

7.1 OVERVIEW

7.2 DRUG DISCOVERY AND DEVELOPMENT

7.3 DISEASE MODELLING

7.4 REGENERATIVE MEDICINE

8 GLOBAL IPS CELL-DERIVED ORGANOIDS MARKET, BY END USER

8.1 OVERVIEW

8.2 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES

8.3 ACADEMIC AND RESEARCH INSTITUTES

8.4 CONTRACT RESEARCH ORGANIZATION

9 GLOBAL IPS CELL-DERIVED ORGANOIDS MARKET, BY REGION

9.1 OVERVIEW

9.1.1 GLOBAL IPS CELL-DERIVED ORGANOIDS MARKET, BY REGION, 2020–2032

9.2 NORTH AMERICA

9.2.1 NORTH AMERICA: IPS CELL-DERIVED ORGANOIDS MARKET, BY COUNTRY, 2020–2032

9.3 EUROPE

9.3.1 EUROPE: IPS CELL-DERIVED ORGANOIDS MARKET, BY COUNTRY, 2020–2032

9.4 ASIA PACIFIC

9.4.1 ASIA PACIFIC: IPS CELL-DERIVED ORGANOIDS MARKET, BY COUNTRY, 2020–2032

9.5 REST OF THE WORLD

9.5.1 REST OF THE WORLD: IPS CELL-DERIVED ORGANOIDS MARKET, BY COUNTRY, 2020–2032

10 COMPETITIVE LANDSCAPE

10.1 INTRODUCTION

10.2 MAJOR GROWTH STRATEGY IN THE GLOBAL IPS CELL-DERIVED ORGANOIDS MARKET

10.3 COMPETITOR DASHBOARD

11 COMPANY PROFILES

11.1 ACROBIOSYSTEMS

11.1.1 COMPANY OVERVIEW

11.1.2 FINANCIAL OVERVIEW

11.1.3 PRODUCTS OFFERED

11.1.4 KEY DEVELOPMENTS

11.1.5 SWOT ANALYSIS

11.1.6 KEY STRATEGIES

11.2 MILTENYI BIOTEC

11.2.1 COMPANY OVERVIEW

11.2.2 FINANCIAL OVERVIEW

11.2.3 PRODUCTS OFFERED

11.2.4 KEY DEVELOPMENTS

11.2.5 SWOT ANALYSIS

11.2.6 KEY STRATEGIES

11.3 THERMOFISHER SCIENTIFIC

11.3.1 COMPANY OVERVIEW

11.3.2 FINANCIAL OVERVIEW

11.3.3 PRODUCTS OFFERED

11.3.4 KEY DEVELOPMENTS

11.3.5 SWOT ANALYSIS

11.3.6 KEY STRATEGIES

11.4 STEMCELL TECHNOLOGIES

11.4.1 COMPANY OVERVIEW

11.4.2 FINANCIAL OVERVIEW

11.4.3 PRODUCTS OFFERED

11.4.4 KEY DEVELOPMENTS

11.4.5 SWOT ANALYSIS

11.4.6 KEY STRATEGIES

11.5 BIO-TECHNE

11.5.1 COMPANY OVERVIEW

11.5.2 FINANCIAL OVERVIEW

11.5.3 PRODUCTS OFFERED

11.5.4 KEY DEVELOPMENTS

11.5.5 KEY STRATEGIES

11.6 MERCK KGAA

11.6.1 COMPANY OVERVIEW

11.6.2 FINANCIAL OVERVIEW

11.6.3 PRODUCTS OFFERED

11.6.4 KEY DEVELOPMENTS

11.6.5 SWOT ANALYSIS

11.6.6 KEY STRATEGIES

11.7 MOLECULAR DEVICES, LLC

11.7.1 COMPANY OVERVIEW

11.7.2 FINANCIAL OVERVIEW

11.7.3 PRODUCTS OFFERED

11.7.4 KEY DEVELOPMENTS

11.7.5 KEY STRATEGIES

11.8 CORNING INCORPORATED

11.8.1 COMPANY OVERVIEW

11.8.2 FINANCIAL OVERVIEW

11.8.3 PRODUCTS OFFERED

11.8.4 KEY DEVELOPMENTS

11.8.5 KEY STRATEGIES

11.9 PROMEGA CORPORATION

11.9.1 COMPANY OVERVIEW

11.9.2 FINANCIAL OVERVIEW

11.9.3 PRODUCTS OFFERED

11.9.4 KEY DEVELOPMENTS

11.9.5 KEY STRATEGIES

11.10 CREATIVE BIOARRAY

11.10.1 COMPANY OVERVIEW

11.10.2 FINANCIAL OVERVIEW

11.10.3 PRODUCTS OFFERED

11.10.4 KEY DEVELOPMENTS

11.10.5 KEY STRATEGIES

LIST OF TABLES

TABLE 1 QFD MODELING FOR MARKET SHARE ASSESSMENT

TABLE 2 GLOBAL: IPS CELL-DERIVED ORGANOIDS MARKET, BY TYPE, 2019–2032 (USD MILLION)

TABLE 3 GLOBAL: IPS CELL-DERIVED ORGANOIDS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 4 GLOBAL: IPS CELL-DERIVED ORGANOIDS MARKET, BY END USER, 2019–2032 (USD MILLION)

TABLE 5 GLOBAL IPS CELL-DERIVED ORGANOIDS MARKET, BY REGION, 2019–2032 (USD MILLION)

TABLE 6 NORTH AMERICA: IPS CELL-DERIVED ORGANOIDS MARKET, BY COUNTRY, 2019–2032 (USD MILLION)

TABLE 7 NORTH AMERICA: IPS CELL-DERIVED ORGANOIDS MARKET, BY TYPE, 2019–2032 (USD MILLION)

TABLE 8 NORTH AMERICA: IPS CELL-DERIVED ORGANOIDS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 9 NORTH AMERICA: IPS CELL-DERIVED ORGANOIDS MARKET, BY END USER, 2019–2032 (USD MILLION)

TABLE 10 USA: IPS CELL-DERIVED ORGANOIDS MARKET, BY TYPE, 2019–2032 (USD MILLION)

TABLE 11 USA: IPS CELL-DERIVED ORGANOIDS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 12 USA: IPS CELL-DERIVED ORGANOIDS MARKET, BY END USER, 2019–2032 (USD MILLION)

TABLE 13 CANADA: IPS CELL-DERIVED ORGANOIDS MARKET, BY TYPE, 2019–2032 (USD MILLION)

TABLE 14 CANADA: IPS CELL-DERIVED ORGANOIDS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 15 CANADA: IPS CELL-DERIVED ORGANOIDS MARKET, BY END USER, 2019–2032 (USD MILLION)

TABLE 16 EUROPE: IPS CELL-DERIVED ORGANOIDS MARKET, BY COUNTRY, 2019–2032 (USD MILLION)

TABLE 17 EUROPE: IPS CELL-DERIVED ORGANOIDS MARKET, BY TYPE, 2019–2032 (USD MILLION)

TABLE 18 EUROPE: IPS CELL-DERIVED ORGANOIDS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 19 EUROPE: IPS CELL-DERIVED ORGANOIDS MARKET, BY END USER, 2019–2032 (USD MILLION)

TABLE 20 GERMANY: IPS CELL-DERIVED ORGANOIDS MARKET, BY TYPE, 2019–2032 (USD MILLION)

TABLE 21 GERMANY: IPS CELL-DERIVED ORGANOIDS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 22 GERMANY: IPS CELL-DERIVED ORGANOIDS MARKET, BY END USER, 2019–2032 (USD MILLION)

TABLE 23 UK: IPS CELL-DERIVED ORGANOIDS MARKET, BY TYPE, 2019–2032 (USD MILLION)

TABLE 24 UK: IPS CELL-DERIVED ORGANOIDS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 25 UK: IPS CELL-DERIVED ORGANOIDS MARKET, BY END USER, 2019–2032 (USD MILLION)

TABLE 26 FRANCE: IPS CELL-DERIVED ORGANOIDS MARKET, BY TYPE, 2019–2032 (USD MILLION)

TABLE 27 FRANCE: IPS CELL-DERIVED ORGANOIDS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 28 FRANCE: IPS CELL-DERIVED ORGANOIDS MARKET, BY END USER, 2019–2032 (USD MILLION)

TABLE 29 ITALY: IPS CELL-DERIVED ORGANOIDS MARKET, BY TYPE, 2019–2032 (USD MILLION)

TABLE 30 ITALY: IPS CELL-DERIVED ORGANOIDS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 31 ITALY: IPS CELL-DERIVED ORGANOIDS MARKET, BY END USER, 2019–2032 (USD MILLION)

TABLE 32 SPAIN: IPS CELL-DERIVED ORGANOIDS MARKET, BY TYPE, 2019–2032 (USD MILLION)

TABLE 33 SPAIN: IPS CELL-DERIVED ORGANOIDS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 34 SPAIN: IPS CELL-DERIVED ORGANOIDS MARKET, BY END USER, 2019–2032 (USD MILLION)

TABLE 35 REST OF EUROPE: IPS CELL-DERIVED ORGANOIDS MARKET, BY TYPE, 2019–2032 (USD MILLION)

TABLE 36 REST OF EUROPE: IPS CELL-DERIVED ORGANOIDS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 37 REST OF EUROPE: IPS CELL-DERIVED ORGANOIDS MARKET, BY END USER, 2019–2032 (USD MILLION)

TABLE 38 ASIA PACIFIC: IPS CELL-DERIVED ORGANOIDS MARKET, BY COUNTRY, 2019–2032 (USD MILLION)

TABLE 39 ASIA PACIFIC: IPS CELL-DERIVED ORGANOIDS MARKET, BY TYPE, 2019–2032 (USD MILLION)

TABLE 40 ASIA PACIFIC: IPS CELL-DERIVED ORGANOIDS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 41 ASIA PACIFIC: IPS CELL-DERIVED ORGANOIDS MARKET, BY END USER, 2019–2032 (USD MILLION)

TABLE 42 CHINA: IPS CELL-DERIVED ORGANOIDS MARKET, BY TYPE, 2019–2032 (USD MILLION)

TABLE 43 CHINA: IPS CELL-DERIVED ORGANOIDS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 44 CHINA: IPS CELL-DERIVED ORGANOIDS MARKET, BY END USER, 2019–2032 (USD MILLION)

TABLE 45 INDIA: IPS CELL-DERIVED ORGANOIDS MARKET, BY TYPE, 2019–2032 (USD MILLION)

TABLE 46 INDIA: IPS CELL-DERIVED ORGANOIDS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 47 INDIA: IPS CELL-DERIVED ORGANOIDS MARKET, BY END USER, 2019–2032 (USD MILLION)

TABLE 48 JAPAN: IPS CELL-DERIVED ORGANOIDS MARKET, BY TYPE, 2019–2032 (USD MILLION)

TABLE 49 JAPAN: IPS CELL-DERIVED ORGANOIDS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 50 JAPAN: IPS CELL-DERIVED ORGANOIDS MARKET, BY END USER, 2019–2032 (USD MILLION)

TABLE 51 SOUTH KOREA: IPS CELL-DERIVED ORGANOIDS MARKET, BY TYPE, 2019–2032 (USD MILLION)

TABLE 52 SOUTH KOREA: IPS CELL-DERIVED ORGANOIDS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 53 SOUTH KOREA: IPS CELL-DERIVED ORGANOIDS MARKET, BY END USER, 2019–2032 (USD MILLION)

TABLE 54 AUSTRALIA: IPS CELL-DERIVED ORGANOIDS MARKET, BY TYPE, 2019–2032 (USD MILLION)

TABLE 55 AUSTRALIA: IPS CELL-DERIVED ORGANOIDS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 56 AUSTRALIA: IPS CELL-DERIVED ORGANOIDS MARKET, BY END USER, 2019–2032 (USD MILLION)

TABLE 57 REST OF APAC: IPS CELL-DERIVED ORGANOIDS MARKET, BY TYPE, 2019–2032 (USD MILLION)

TABLE 58 REST OF APAC: IPS CELL-DERIVED ORGANOIDS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 59 REST OF APAC: IPS CELL-DERIVED ORGANOIDS MARKET, BY END USER, 2019–2032 (USD MILLION)

TABLE 60 REST OF THE WORLD: IPS CELL-DERIVED ORGANOIDS MARKET, BY COUNTRY, 2019–2032 (USD MILLION)

TABLE 61 REST OF WORLD: IPS CELL-DERIVED ORGANOIDS MARKET, BY TYPE, 2019–2032 (USD MILLION)

TABLE 62 REST OF WORLD: IPS CELL-DERIVED ORGANOIDS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 63 REST OF WORLD: IPS CELL-DERIVED ORGANOIDS MARKET, BY END USER, 2019–2032 (USD MILLION)

TABLE 64 MIDDLE EAST & AFRICA: IPS CELL-DERIVED ORGANOIDS MARKET, BY TYPE, 2019–2032 (USD MILLION)

TABLE 65 MIDDLE EAST & AFRICA: IPS CELL-DERIVED ORGANOIDS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 66 MIDDLE EAST & AFRICA: IPS CELL-DERIVED ORGANOIDS MARKET, BY END USER, 2019–2032 (USD MILLION)

TABLE 67 SOUTH AMERICA: IPS CELL-DERIVED ORGANOIDS MARKET, BY TYPE, 2019–2032 (USD MILLION)

TABLE 68 SOUTH AMERICA: IPS CELL-DERIVED ORGANOIDS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 69 SOUTH AMERICA: IPS CELL-DERIVED ORGANOIDS MARKET, BY END USER, 2019–2032 (USD MILLION)

TABLE 70 ACROBIOSYSTEMS: PRODUCTS OFFERED

TABLE 71 ACROBIOSYSTEMS: KEY DEVELOPMENTS

TABLE 72 MILTENYI BIOTEC: PRODUCTS OFFERED

TABLE 73 THERMO FISHER SCIENTIFIC INC: PRODUCTS OFFERED

TABLE 74 STEMCELL TECHNOLOGIES: PRODUCTS OFFERED

TABLE 75 BIO-TECHNE CORP: PRODUCTS OFFERED

TABLE 76 MERCK KGAA: PRODUCTS OFFERED

TABLE 77 MOLECULAR DEVICES.: PRODUCTS OFFERED

TABLE 78 CORNING INCORPORATED: PRODUCTS OFFERED

TABLE 79 PROMEGA CORPORATION.: PRODUCTS OFFERED

TABLE 80 CREATIVE BIOARRAY: PRODUCTS OFFERED

LIST OF FIGURES

FIGURE 1 GLOBAL IPS CELL-DERIVED ORGANOIDS MARKET: STRUCTURE

FIGURE 2 MARKET DYNAMICS: GLOBAL IPS CELL-DERIVED ORGANOIDS MARKET

FIGURE 3 DRIVER IMPACT ANALYSIS: GLOBAL IPS CELL-DERIVED ORGANOIDS MARKET

FIGURE 4 RESTRAINT IMPACT ANALYSIS: GLOBAL IPS CELL-DERIVED ORGANOIDS MARKET

FIGURE 5 PORTER’S FIVE FORCES ANALYSIS: GLOBAL IPS CELL-DERIVED ORGANOIDS MARKET

FIGURE 6 SUPPLY CHAIN ANALYSIS: GLOBAL IPS CELL-DERIVED ORGANOIDS MARKET

FIGURE 7 GLOBAL IPS CELL-DERIVED ORGANOIDS MARKET, BY TYPE, 2023 (% SHARE)

FIGURE 8 GLOBAL IPS CELL-DERIVED ORGANOIDS MARKET, BY TYPE, 2019–2032 (USD MILLION)

FIGURE 9 GLOBAL IPS CELL-DERIVED ORGANOIDS MARKET, BY APPLICATION, 2023 (% SHARE)

FIGURE 10 GLOBAL IPS CELL-DERIVED ORGANOIDS MARKET, BY PRICING, 2019–2032 (USD MILLION)

FIGURE 11 GLOBAL IPS CELL-DERIVED ORGANOIDS MARKET, BY END USER, 2023 (% SHARE)

FIGURE 12 GLOBAL IPS CELL-DERIVED ORGANOIDS MARKET, BY AGE CATEGORY, 2019–2032 (USD MILLION)

FIGURE 13 GLOBAL IPS CELL-DERIVED ORGANOIDS MARKET, BY REGION, 2023 (% SHARE)

FIGURE 14 GLOBAL IPS CELL-DERIVED ORGANOIDS MARKET, BY REGION, 2019-2032 (USD MILLION)

FIGURE 15 NORTH AMERICA: IPS CELL-DERIVED ORGANOIDS MARKET SHARE, BY COUNTRY, 2023 (% SHARE)

FIGURE 16 EUROPE: IPS CELL-DERIVED ORGANOIDS MARKET SHARE, BY COUNTRY, 2023 (% SHARE)

FIGURE 17 ASIA PACIFIC: IPS CELL-DERIVED ORGANOIDS MARKET SHARE, BY COUNTRY, 2023 (% SHARE)

FIGURE 18 MIDDLE EAST & AFRICA: IPS CELL-DERIVED ORGANOIDS MARKET SHARE, BY COUNTRY, 2023 (% SHARE)

FIGURE 19 COMPETITOR DASHBOARD: GLOBAL IPS CELL-DERIVED ORGANOIDS MARKET

FIGURE 20 ACROBIOSYSTEMS: SWOT ANALYSIS

FIGURE 21 MILTENYI BIOTEC: SWOT ANALYSIS

FIGURE 22 THERMO FISHER SCIENTIFIC INC: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 23 THERMO FISHER SCIENTIFIC INC: SWOT ANALYSIS

FIGURE 24 STEMCELL TECHNOLOGIES: SWOT ANALYSIS

FIGURE 25 MERCK KGAA: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 26 MERCK KGAA: SWOT ANALYSIS

FIGURE 27 CORNING INCORPORATED: FINANCIAL OVERVIEW SNAPSHOT

バイオ技術の最新記事8件